Canaccord analyst Richard Close lowered the firm’s price target on HealthStream (HSTM) to $29 from $30 and keeps a Hold rating on the shares. The firm said they reported 1Q’25 results which fell below Canaccord and consensus estimates as well as a reduction in 2025 guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM: